Podcasts about Acton

TVC 743.6: Cindy Mitchum, youngest daughter of John Mitchum and the niece of Robert Mitchum, talks to Ed about the time when her dad helped his friend Father Latimer Garrett, an Episcopal priest, raise the money needed to build Father Garrett's Boys Ranch, a foster care facility in Acton, California. Them Ornery Mitchum Boys is available in hardcover and in paperback through Henry Gray Publishing, Amazon.com, and JohnMitchum.com. John Mitchum's Unabashed Love of Country, Cowboys, and God is available at CD Baby, Amazon.com, and JohnMitchum.com. Photo of John Mitchum courtesy MitchumMedia.com Cindy Mitchum will appear at Side Show Books, 1639 South La Cienega Blvd., Los Angeles, CA on Monday, July 20, beginning at 8pm. Cindy will sign copies of Them Ornery Mitchum Boys, followed by a screening the original Cape Fear (1962) starring Robert Mitchum. Cindy will also appear, along with Julie Rogers Pomilia and Mari Deese Hampton, at the annual National Day of the Cowboy weekend celebration in Tombstone, Arizona from July 23 through July 26.

GOP Strategist weighs in on Trump's speech from last week, the race for Governor and more

Mike and Duncan are far too hot and burning through t-shirts. It's the summer and we chat about lunch with Tormore, whilst Donuts has visited Bimber Distillery in Acton, London. Whisky tales, DIY men's fragrances... and don't mention the football.You can ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠buy us a dram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ which will make us very happy, and we will shout you out. Check out the Honest to a Malt ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠podcast website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ & blog. Browse the ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Whisky T-Shirt Shop⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Email us on: ⁠HonestToAMalt@protonmail.com

Who is Gwen?Gwen Acton, PhD, has built her career helping “rocket scientists”—the brilliant scientists, engineers, and technical experts behind today's most innovative companies—become extraordinary leaders. With a background spanning everything from biology to technology, Gwen was inspired by the crucial roles these experts play in industries like biotech, aerospace, AI, big pharma, and government research labs. She saw that while technical leaders are essential for organizational success, many find themselves suddenly tasked with leading teams, often without the tools or training to do so. Gwen made it her mission to bridge this gap, coaching and advising growth-stage companies and R&D groups so their top technical minds can excel both as experts and as leaders.Key TakeawaysSummaryStuart Webb and Gwen Acton PhD discuss* Why technical expertise doesn't equate to leadership proficiency* Common pitfalls technical leaders face (like micromanagement and letting go of control)* The mindset shift required to move from individual contributor to successful team leader* The most essential skills and behaviors for leadership in science and technology-driven organizations* Practical advice for influencing up, engaging teams, and leading transformation* Insights from Gwen's career and highlights from her book, “Leadership for Scientists and Engineers”* Audience questions on changing leaders' minds and the hallmarks of great leadershipWhether you're a new leader, a technical expert on the rise, or simply curious about the bridge between science and leadership, this episode delivers actionable tips and inspirational stories.Timestamps & Overview* 00:00 - Tech glitches and introductions:Stuart Webb kicks off, introducing Gwen Acton PhD, her background, and the episode setup.* 01:24 - Defining the technical leader's challenge:Gwen explains who she helps and the need for leadership skills in technical organizations.* 04:10 - Why technical backgrounds don't prepare you for leadership:Gwen highlights the crucial differences between technical problem-solving and managing people, and why logic alone isn't enough for people problems.* 07:04 - The confusion and blind spots of technical leaders:Discussion about why what worked as a technical expert often fails in leadership, and the importance of learning new interpersonal skills.* 09:16 - Letting go and the pains of delegation:Gwen addresses micromanagement, the struggle to trust others, and methods for successful delegation in high-precision environments.* 11:29 - One piece of leadership advice:Why great leaders ask more (and better) questions instead of always trying to provide answers.* 13:24 - Audience Q&A – Changing minds and influencing up:Gwen shares tips for helping leaders change direction, including the power of genuine questions and one-on-one influence.* 17:05 - Gwen's journey from scientist to leadership expert:Personal story about her path, why group dynamics and leadership in science are so important, and practical solutions for the technical world.* 20:20 - About the book “Leadership for Scientists and Engineers”:What readers will find inside and why it's designed as a practical guide for technical leaders.* 21:34 - What makes a good leader or role model?:Key traits and behaviors ranging from strategic alignment to offering feedback and motivating teams.* 26:48 - The killer question: What separates great leaders from those who plateau?:Gwen's reflections on lifelong learning, intentional skill development, and the humility to accept feedback.* 29:28 - Closing remarks and staying in touch:How to subscribe for future episodes, more about Gwen, and reaching out with questions.Resources and Links*

Hi, I'm Connor with Honor - message me here!

The 16th episode of the fourth season of the BBC anthology series Play for Today, Penda's Fen – originally broadcast on 21 March 1974 – is widely celebrated as a visionary masterpiece of British folk horror and 1970s television drama. Written by David Rudkin and directed by Alan Clarke, Time Out London named it one of the 100 best British films. The Visionary Realism of Alan ClarkeDirector Alan Clarke is renowned for his stark social realism and controversial depictions of institutionalised communities. His 1977 borstal drama Scum was banned by the BBC, later returning as a 1979 feature film, while his television film Made in Britain introduced Tim Roth as a racist skinhead. He tackled corporate corruption in Beloved Enemy, military interrogation in Psy-Warriors, and directed David Bowie in Bertolt Brecht's Baal. His final work, The Firm starring Gary Oldman, drew heavy press criticism for its depiction of violent football hooliganism in Thatcher's Britain.While Penda's Fen trades Clarke's urban realism for a mystical landscape of angels and demons, it retains his fierce preoccupation with identity, authority, and systemic oppression.Cult Television & Audio ConnectionsThe surreal atmosphere is driven by an electronic score from Paddy Kingsland of the BBC Radiophonic Workshop. Kingsland manipulated a Benjamin Britten recording for the play, and went on to score The Changes, the radio and TV versions of The Hitchhiker's Guide to the Galaxy, and classic Doctor Who serials.The cast links directly to landmark British cult media:Spencer Banks (Stephen Franklin): The quintessential 1970s television adolescent, Banks also starred as Simon Randall in the children's sci-fi series Timeslip.Georgine Anderson (Mrs Franklin): A veteran of the Royal Shakespeare Company who later played May in the 2007 Doctor Who episode ‘Gridlock' – representing the show's first married same-sex couple.Ian Hogg (Arne): Famous as the lead in Rockliffe's Babies and the villainous Josiah Samuel Smith in the Doctor Who story Ghost Light.Jennie Hesselwood (Mrs Arne): Mother of Toby Jones and wife of Freddie Jones (Dune, The Elephant Man).Graham Leaman (Sir Edward Elgar): Features a massive Doctor Who pedigree including The Macra Terror (tying directly back to the Macra in ‘Gridlock'), The Seeds of Death, and The Three Doctors.Ivor Roberts (Cooke): A familiar face from the ‘Croftiverse' comedies Oh, Doctor Beeching! and You Rang, M'Lord?, as well as Genesis of the Daleks.Ron Smerczak (Joel): Later transitioned to action cinema in American Ninja 4: The Annihilation and Cyborg Cop.Current Promotions & EventsThe General Witchfinders Book Club: Our debut spin-off episode is out now, run with independent bookshop Teaseland & Skylark in Dorchester. Host Ross welcomes author Ray Newman (The Grave Digger's Boy) to unpack Andrew Michael Hurley's folk horror novel, Starve Acre. Listen here: https://tinyurl.com/GW-BC-01Summer Spin-Off – Department X: Join James and Ross as they investigate the 1970s obsession with ESP, telekinesis, and psychic premonitions. Listen to 'Mysterious Powers & Strange Forces' here: https://tinyurl.com/MYSpowerLondon Halloween Live Show: We are taking over ActOne Cinema in Acton on Friday 30th October at 7:30pm for a screening of Hammer's Dr. Jekyll and Sister Hyde and a live podcast recording. Tickets are £14: https://tinyurl.com/DRJeky11'Hammer Presents' Blu-ray Giveaway: Win a bundle of restored rarities including The Snake Woman, Dr. Blood's Coffin, Cry of the Banshee, and Crucible of Horror. Enter before Friday 31st July: https://tinyurl.com/HamPrizeGeneral Witchfinders Issue 4: Grab our 76-page zine of unsettling folk horror fiction, original artwork, and deep-dive features: https://tinyurl.com/gwZINESupport this show http://supporter.acast.com/general-witchfinders. Hosted on Acast. See acast.com/privacy for more information.

"Great is the Lord Jesus Christ" — Jesus is preached, Jesus is received, Jesus is held in high honor, and Jesus is the only way. The real question isn't whether Jesus is part of your life. It's whether he's the center of it. Because if Jesus is not the center of all, he is not the center at all. Whether you've been following Jesus for decades or you're still figuring out what you believe — this one is for you.

Emma is a high achieving, middle class woman from West London - she's destined for a successful career and a comfortable British life. But in 2001 she makes a decision that will come to define her - she marries the son of a dictator and becomes Asma al-Assad, the first lady of Syria.We call her Emma is a 6 part original series from Tortoise Investigates and The Observer.To binge listen to all episodes today, ad-free, subscribe to The Observer and use the code AUDIO50 to get 50% off your annual subscription.You'll get access to:This series and all our podcasts before anyone elseAd-free listeningPremium newslettersPuzzles from the inventors of the cryptic crosswordExclusive offers from our partners including Mubi and iescapeTickets to join Observer events in our newsroom or onlineOr subscribe to Observer+ on Apple Podcasts or Spotify to listen to all our podcasts, including this one, without any ads.Reporter - Chloe HadjimatheouProducer - Gary MarshallSound design - Karla PatellaPodcast artwork - Lola Williams & Eliza BournerExecutive producers - Jasper Corbett and Basia Cummings Hosted on Acast. See acast.com/privacy for more information.

This is an exciting episode of the show as we welcome two of our favorite guests... starting off with Dan Acton, who, despite what you may have read, will not put a dentist coat on for cash. He joins Michelle to unpack her day from hell, including getting hit by a bike and falling in front of an audience. Luckily Mich has a bright FINN DOM future ahead (or so she hopes), but will it be in time to score a million-dollar ticket to Wimbledon? Then!! We welcome comedian and mega-producer Jamie Lee to the show to try our best not to gossip about J-Lo. We unpack grief and the shock of losing a friend young, which is the main subject matter of her new one-woman show My Friend Katy, which will be on a stage near you in no time.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Bell Brothers and the Collaborative Creation of Novels. Guest: Deborah Lutz. Lutz explains how the sisters published their poetry under the pseudonyms Currer, Ellis, and Acton Bell to avoid gender bias. Despite selling only two copies, they immediately began collaborating on their first novels. Lutz also explores the troubled life of their brother, Branwell. 9CHARLOTTE BRONTE

The U.S. and Israel just fought a second war over Iran's nuclear program—and one of the world's leading nuclear experts says America lost. Iran's uranium stockpile sits fully intact in tunnels too deep to reach, and Tehran walked away with more leverage in nuclear talks. James Acton, a physicist and longtime analyst of Iran's program, joins host Jon Bateman on The World Unpacked to give a detailed update on this crisis. Has the new supreme leader already decided to build a weapon? How quickly could Iran “break out” or “sneak out” to the bomb? And why does Acton now expect more wars—followed by a nuclear detonation? Host: Follow Jon on X: https://x.com/JonKBateman  Guest: James Acton: https://x.com/james_acton32?lang=en   

Back from his trip to Brazil, Dan Acton is here to recap the road to Brazil and all the joys of traveling through one of the most beautiful places on Earth with waves that will literally rip the glasses from you head. This is an episode CHOCK FULL of info: Going to World Cup games to meet "hunks"... assuming StubHub hasn't scammed you out of tickets, on the other hand "singlemaxxing," unkempt hovels, documentaries ranging from stolen Lego sets to stolen Disney memoribilia #WheresBuzzy, patchouli and passing the Zara sniff test, and twerking against your will at the Knicks parade.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Devin Acton is an obsessed tuna fisherman, an analytical bass angler, and a talented writer. In this episode, Devin and Jimmy talk about the glidebait bubble, fractional fish reports, Panamanian yellowfin, Cape Cod bluefin, and days of wind and darkness. Check out the Salvage: https://blowinwegoin.substack.com?utm_source=navbar&utm_medium=webFollow Devin on Instagram: Instagram

https://www.actonecinema.co.uk/movie/general-witchfinders-present-dr-jekyll-sister-hyde/We are bringing General Witchfinders to London on Halloween-eve – Friday 30th October at 7:30pm.We really want to make this night a success – and by success, we mean not spending a load of money just to watch a film in a cinema all on our own! If you can make it, please grab a ticket and bring along a Hammer-friendly friend or two to help us fill the room. We would also massively appreciate your help to spread the word so we can reach as many people as possible.We are teaming up with ActOne Cinema in Acton for a big-screen outing of Hammer's Dr Jekyll and Sister Hyde, followed by a live podcast recording.Tickets are £14 and available now.https://www.actonecinema.co.uk/movie/general-witchfinders-present-dr-jekyll-sister-hyde/If you can tell everyone you know, it would mean the world to us.ActOne Cinema, 119 – 121 High Street, London, W3 6NAActon Town (Tube) and Acton Central (Overground). Bus routes 70, 266, 440, E3, 207, SL8, and 218 stop nearby. Salisbury Street car park is a two-minute walk away.Support this show http://supporter.acast.com/general-witchfinders. Hosted on Acast. See acast.com/privacy for more information.

A quiet evening hike through Hueston Woods State Park in Ohio left Olivia with more questions than answers.While exploring the Big Woods Trail near sunset, she noticed unusual tree formations, a sudden silence in the forest, rustling movement off the trail, and an overwhelming feeling that something was watching her. The experience stayed with her long after she returned home. When she reviewed her footage, she discovered something unexpected hidden among the trees.The story didn't end there.A BFRO investigator later visited the location and reportedly found large footprints near the same area. Olivia returned multiple times herself, uncovering additional tracks and gathering more evidence from a location that may hold a history of unexplained activity.She also shares an earlier nighttime experience from the same park near Acton Lake, where an unseen presence moved through dense vegetation and appeared to approach her position after dark.Could these events be connected? What is happening in one of Ohio's most popular state parks?Join us as Olivia shares her firsthand experiences from Hueston Woods and explains why she plans to continue searching for answers.Resources: https://www.youtube.com/watch?v=rRg6WxTF2yA&t=1543s

What if the entrepreneurial principles you spent your 20s and 30s learning the hard way — accountability, financial literacy, win-win thinking — could be baked into your kids' education from the very beginning? David Richter shares the story of how a conversation at a real estate investor mastermind led his family to discover Acton Academy, a nontraditional school with an entrepreneurial framework so aligned with how he runs his business that they eventually moved across the country to enroll their daughter.This episode isn't a sponsored segment — it's a genuine recommendation from someone who watched his six-year-old come home and propose a win-win negotiation without ever being taught the term. From peer accountability contracts and level-based progression to real-world apprenticeships and early financial literacy, David breaks down what makes Acton different and why the principles behind it translate directly to how successful investors build teams, hire by core values, and think about the next generation.Timeline Highlights[0:23] David introduces the episode: the question of how to pass down hard-won business lessons to your kids earlier than you learned them[1:03] The mastermind conversation that introduced David to Acton Academy and why the word "nontraditional" immediately caught his attention[1:35] The book that started it all: Laura Sandefer's Courage to Grow, and how both David and his wife reacted to reading it[2:38] Why Acton's model resonated with David's EOS-based business: accountability, buy-in, and team ownership over top-down directives[3:29] How David's family searched for an Acton campus, eventually relocating to Florida specifically for the school[3:52] The guide vs. teacher distinction: why Acton calls classrooms "studios" and instructors "guides," and what that signals about the learning philosophy[5:17] The peer accountability contract: how students write and sign their own code of conduct at the start of each year and enforce it with each other[6:16] Level-based progression instead of grades: how students move at their own pace by earning badges across academic and social-emotional skills[7:14] The apprenticeship program for junior high and high school students, and what that would have meant for a young real estate investor[8:16] Financial literacy built into the curriculum: from basic money concepts in elementary to reading a profit and loss statement in high school[9:09] The moment David's daughter, then six years old, came home and proposed a win-win solution — a concept he didn't encounter until reading the Seven Habits of Highly Effective People in his 20s[10:04] David's closing encouragement: whether you're already enrolling kids or just starting a family, there are alternatives worth researchingKey TakeawaysThe same principles that make great business operators — accountability, buy-in, core values, and peer enforcement — can be taught to kids in a school environment designed around them, not just added on as life lessons later.Acton Academy's peer accountability contract mirrors what strong companies do with core values: students write the standards themselves, hold each other to them, and face real consequences for repeated violations. That kind of accountability, learned young, is rare.Level-based progression removes the arbitrary pressure of grade advancement and lets students move at their own pace while building a more honest picture of mastery — a more honest model than a lot of corporate performance reviews, too.The apprenticeship structure Acton uses in secondary school gives students the kind of hands-on, real-world exposure that most real estate investors had to pay a coach or mentor for in their 30s. Starting that exploration at 14 instead of 34 changes the trajectory.Financial literacy — reading a profit and loss statement, understanding a balance sheet — is embedded in the Acton curriculum. Most real estate investors learn this through painful trial and error. Teaching it to kids before they ever start a business is a significant edge.The best businesses invest in teaching their teams the things they need to know. The same logic applies to your kids. If your school isn't teaching entrepreneurial thinking, accountability, and financial basics, it may be worth asking whether there's a better option.Links & ResourcesActon Academy — actonacademy.orgCourage to Grow by Laura Sandefer — available at major booksellersSimple CFO Solutions — apply for a free financial discovery call: https://simplecfo.comClosingIf you've ever wished someone had taught you financial literacy, accountability, or how to think like an entrepreneur before you had to learn it the expensive way, this episode is worth passing along. Subscribe to Profit First for Real Estate Investors so you don't miss future Case Files and guest conversations, and if you're ready to bring clarity and structure to your business finances, visit profitrei.com to get started.

Jules Acton is a British environmentalist, author of Oaklore, and ambassador for the Woodland Trust. In this episode, we explore the enchanting world of oak trees, from the tiny creatures that live in them to the interconnected life around them, and how these trees weave through human history, culture, and life.Connect and Learn More Book: Oaklore Website: julesacton.com LinkedIn: linkedin.com/in/jules-acton-574b0522 Instagram: @julieblowfishResourcesBooksEntangled Life by Merlin SheldrakeThe Hidden Life of Trees by Peter WohllebenOrganizations & ProjectsWoodland TrustNature's Calendar (by the Woodland Trust)

This week on Purple Political Breakdown Ohio Edition, Radell Lewis follows the money and the power across Ohio politics and keeps circling one question: who is Ohio's government actually working for? Radell opens with the biggest and newest story, the FBI search of the Cleveland offices of the Ohio Organizing Collaborative, a progressive group that registers voters, and why the timing and the target deserve a hard, skeptical look. He revisits the FirstEnergy corruption scandal as the real, provable Ohio fraud story, then breaks down a busy week at the Statehouse: the two voter ID measures (Senate Joint Resolution 10, the constitutional amendment headed for the November ballot, and House Bill 472, the absentee photo ID copy requirement now sitting on the governor's desk), the data center tax break that lawmakers promised to end and then quietly kept, the Medicaid anti-fraud bill, and the 3.7 billion dollar capital budget. Then it is the races. The Senate fight between Sherrod Brown and Jon Husted, including the dueling Epstein attack ads and what is actually true about the Wexner donations, Husted's vote on Trump's anti-weaponization fund, and the latest polling that pushed Cook Political Report to move the seat to toss-up. The governor's race between Amy Acton and Vivek Ramaswamy, where Radell digs into Ramaswamy's tax plan, the independent cost estimates, and his own financial disclosure. And a full District Watch on Ohio's 4th and 5th, where Radell lays out exactly what Jim Jordan and Bob Latta stand for and what their challengers, Joshua Kolasinski and Brian Shaver, are offering instead. County of the Week is Butler County. Radell shares who he is voting for and why, makes the case for showing up even in deep red districts, and keeps it where he always does: political solutions without political bias, building a better Ohio on the way to a better America. [CANONICAL RESOURCE BLOCK FOLLOWS. Append your standard block verbatim here. The verified tail is below. Please paste your exact top lines, the PODCAST NETWORK line and the HeadOn entry above the headon.ai link, since I do not have those two verbatim.] [PASTE: PODCAST NETWORK line and HeadOn entry here] [Confirm the rest of your standard block matches your last published description: CONVERSATION PLATFORMS, UNITY MOVEMENTS, BALANCED NEWS, VOTING REFORM, POLITICAL ENGAGEMENT including the PPB Substack subscribe link https://open.substack.com/pub/purplepoliticalbreakdown, DAILY NEWS text line, and the all-links Linktree at purplepoliticalbreakdown.com] We believe in the power of conversation, balanced information, and democratic participation to build a stronger society. Our mission: "Political solutions without political bias." Subscribe, rate, and share if you believe in purple politics, where we find common ground in the middle. Also if you want to be a part of the community and the conversation, make sure to Join the Discord: https://discord.gg/ptPAsZtHC9

It's in the News! The top diabetes stories and headlines happening now. Top stories this week include: Afrezza inhaled Insulin is Approved for Kids, CGM + Ketone Monitor gets European approval, Food Coloring & Diabetes Study, Device Recalls include Omnipod and Dexcom, Beta Bionics shares more about their patch pump, ADA conference info and more! This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcripts: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. ADA starts this week – safe travels to those of you heading to New Orleans. We'll be covering remotely so please follow on social – make sure to Like the FB page or join the group. We've got a wrap up episode planned for this podcast as well as some indepth interviews with the newsmakers from the conference. I will see some of you next week in Chicago. We have a couple of seats left for our Club 1921 dinner on June 10th in Northbrook – this is a FREE dinner for HCPs and patient leaders – all about screening for T1D. More info on the website under the events tab. Okay.. our top story this week: XX Afrezza inhaled insulin is now approved for kids and teens. The FDA okayed MannKind's afrezza for children 6 and older with type 1 and type 2 diabetes. MannKind says its proprietary Technosphere drug delivery platform enables the rapid absorption of insulin into systemic circulation. This follows FDA approval earlier this year for an update that revises recommendations for the starting mealtime dosage when patients switch from subcutaneous mealtime insulin regimens. MannKind also completed enrollment in February for a study evaluating the initiation of Afrezza therapy shortly after type 1 diabetes diagnosis in pediatric patients.   The company said it made Afrezza available for eligible patients for $35 or less per month. Desmond Schatz, professor of pediatrics at the University of Florida College of Medicine, said: "Mealtime insulin can be especially challenging for children because eating and snacking patterns, activity levels, and daily settings like school and sports often vary. With its rapid onset and dosing at the start of a meal, Afrezza may help clinicians better match insulin therapy to how children and families live day to day, while offering a needle-free mealtime option." Lots more to come on this – we're working on a bonus episode with one of the pediatric endos who worked on the clinical trials that led to this approval – hopefully have that out later this week. https://www.massdevice.com/mannkind-fda-approval-inhaled-insulin-children/ XX FDA has agreed to consider a new drug for the treatment of adults with type 1 and chronic kidney disease. Finerenone (fy-near-uh-known) is currently approved in the US for adults with CKD associated with type 2 diabetes and for adults with heart failure with left ventricular ejection fraction of 40% or greater. Chronic kidney disease (CKD) is present in over one-third of adults with diabetes, and because it's such a serious condition, interventions are needed to reduce its incidence and help people live a long and prosperous life. https://www.docwirenews.com/post/fda-grants-priority-review-to-finerenone-snda-for-type-1-diabetes-associated-ckd XX Abbot gets European approval for the world's first dual glucose‑ketone sensing technology for people with diabetes. They're calling this Libre Duo and Libre Duo 10 Day, and it's designed to continuously measure glucose and ketone levels every minute. Abbott plans to begin launching Libre Duo systems in select European countries later this year. Libre Duo delivers up to 15 days of wear and will be offered to adults ages 18 and older. Libre Duo 10 Day offers up to 10 days of wear and is intended for people ages 2 and older. Abbott is also working with leading pump companies to allow automated insulin delivery (AID) systems to connect with the sensors. https://abbott.mediaroom.com/2026-05-27-Abbott-secures-CE-Mark-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes   XX Huge recall for Omnipod. Insulin says a manufacturing issue through ongoing product monitoring that could result in insulin under-delivery  with specific lots of its Omnipod 5, Dash and Eros pods. Insulet said the scope of this action reaches approximately 7 million pods. This issue is separate from the March recall that affected certain Omnipod 5 lots. According to the Acton, Massachusetts-based company, some of its affected pods may have a small tear in the tubing (cannula) just above the skin. This tear lands between the pod and the point where the cannula enters the body. If this occurs, insulin may leak outside of the device instead of being fully delivered into the body as intended. This may lead to under-delivery of the therapeutic.   Individuals using an affected pod may notice wetness on the skin or pod adhesive or detect the smell of insulin. However, some cases may prove difficult to detect and go unnoticed. Of the approximately 7 million pods included in the action, approximately 60% have been consumed or are expired. The pods affected by the correction represent approximately 8.5% of the 2025 global Omnipod pod prodcution. Insulet says it has sufficient supply to replace affected pods. It expects no disruption to product availability. The company said it has notified the FDA and all other relevant regulatory authorities of its action.   The full list of affected pod lots can be found here. https://www.massdevice.com/insulet-another-omnipod-5-recall-dash-eros/ XX Dexcom is warning that certain scrapped glucose sensors have been stolen and resold. Dexcom said it has not received any reports of severe adverse events associated with the stolen product. One lot of scrapped devices carries a risk of infection for sensors that are not properly sterilized, and another lot had an elevated internal testing failure rate, meaning users would have an increased risk of having no sensor readings available. Dexcom said the affected sensors were stolen during the destruction process and then sold by third parties. The company routinely scraps sensors that do not meet its standards. The sensors are sent to a third-party vendor for destruction and recycling.   Dexcom said it traced sales of the stolen devices to Pharmsource, which is not an authorized Dexcom distributor but supplies some independent pharmacies and U.S. durable medical equipment distributors. Because of this, pharmacies that purchase products from Pharmsource should review their inventory, Dexcom said.   People with sensors from the affected lots should not use those sensors and can call customer support to request replacements. Dexcom has set up a website to help users check if their devices are affected. https://www.medtechdive.com/news/dexcom-warns-of-scrapped-glucose-sensors-being-resold/821139/ XX XX   Beta Bionics plans to debut its first insulin patch pump by the end of the second quarter of 2027, subject to Food and Drug Administration clearance. The device, called Mint, would be compatible with Beta Bionics' interoperable automated glycemic controller, a software that allows for the pump to automatically adjust insulin delivery based on readings from a glucose sensor. Beta Bionics first unveiled the prototype for Mint last year at the American Diabetes Association's Scientific Sessions. The device is expected to have a similar size and wear time, at three days, to Insulet's patch pumps on the market. It would have a 200-unit insulin reservoir.   Mint differs by containing a mix of reusable and disposable components. Beta Bionics plans to make the device exclusively available in the pharmacy channel, building on its existing agreements for its current iLet insulin pump. Beta Bionics is one of several diabetes tech companies developing patch pumps to compete with market leader Insulet. Tandem Diabetes Care and Medtronic spinoff MiniMed have also announced planned patch pumps. Tandem said it plans to file a 510(k) submission this quarter for a tubeless version of its small, durable pump, and Medtronic plans to submit its patch pump to the FDA this fall.   https://www.medtechdive.com/news/beta-bionics-to-launch-its-first-insulin-patch-pump-to-compete-with-insulet/821091/ XX CVS puts Zepbound back on it's coverage list – with it's Caremark PBM. They also added Foundayo, Lilly's obesity pill. CVS had dropped Lilly's Zepound last summer but kept competitor Wegovy. It'll be back at Caremark October first. All three of the nation's largest pharmacy ⁠benefit managers ​now cover Lilly's full obesity medicine portfolio. https://www.reuters.com/legal/litigation/cvs-brings-back-coverage-lillys-obesity-drug-zepbound-2026-05-28/   More to come, including a new benefit from metformin for women, something new from Tidepool, big news for T1D in Austalia and more.. XX A new study suggests that higher long-term exposure to food colouring additives — including both synthetic and natural colourings commonly found in processed foods and beverages — may be associated with an increased risk of developing type 2 diabetes. Researchers analyzed data from more than 108,000 adults in the French NutriNet-Santé cohort between 2009 and 2023, following participants for a median of just over eight years. During that time, 1,131 participants developed type 2 diabetes. The study found that people with the highest intake of total food colouring additives had a 38% higher risk of developing type 2 diabetes compared with non- or low-consumers.   Several specific additives were linked to increased risk, including caramel colouring additives such as total caramel (E150 family), plain caramel (E150a), sulphite ammonia caramel (E150d), and beta-carotene (E160a). Additional associations were observed for curcumin (E100), anthocyanins (E163), paprika extract (E160c), lutein (E161b), and cochineal-derived colourings (E120). "Our findings revealed positive associations between widely consumed food colouring additives and type 2 diabetes incidence," the authors wrote, adding that further research is needed to better understand the mechanisms behind the findings and whether food colouring regulations should be reevaluated. https://www.medscape.com/viewarticle/use-common-food-colours-tied-high-type-2-diabetes-risk-2026a1000hes XX Big news for Australia – their Therapeutic Goods Administration (TGA) approves Tzield. Tzield is now approved in Australia to delay the onset of stage 3 (or clinical) T1D in people aged eight years and older with stage 2 T1D – the early, pre-symptomatic stage of the condition, where changes in blood glucose levels have begun but insulin therapy is not yet required. Breakthrough T1D Australia Chief Executive Officer, Sydney Yovic, said the approval represented a transformational moment for Australians affected by T1D. https://newshub.medianet.com.au/2026/05/landmark-approval-of-tzield-in-australia-ushers-in-a-new-era-of-delay-for-type-1-diabetes/155036/ XX https://www.theatlantic.com/health/2026/05/diabetes-pregnancy/687324/ XX A common diabetes drug may hold great potential to help with aging, even if scientists aren't exactly sure why. According to a study, the drug metformin doesn't just help patients to effectively manage their type 2 diabetes. it may also give older women a better chance of living to 90. Scientists in the US and Germany used data from a long-term US study of postmenopausal women.   Records for a total of 438 people were selected – half of whom took metformin to treat diabetes, and half of whom took a different diabetes drug, sulfonylurea.   While there are some caveats and asterisks to the study, those in the metformin group were calculated to have a 30 percent lower risk of dying before the age of 90 than those in the sulfonylurea group. The study used age 90 as the marker for 'exceptional' longevity. However, scientists aren't yet sure that the drug extends lifespan, especially in humans – which is part of the reason for this study. RCTs could follow further down the line to dig deeper into these results, the researchers suggest. In the meantime, as the global population continues to skew older, studies continue to find ways to keep us healthier for longer and reduce damage to the body as we age. https://www.sciencealert.com/a-common-diabetes-drug-is-linked-with-exceptional-longevity-in-women XX The American Diabetes Association® (ADA) will host the 2026 Scientific Sessions from June 5-8 in New Orleans. The ADA's Scientific Sessions is the world's largest diabetes meeting, convening an expected audience of over 12,000 leading physicians, scientists, researchers, and healthcare professionals from around the globe. The premier diabetes meeting, which is also offered virtually, will feature the latest scientific findings in diabetes and obesity, where leading experts and peers will share findings in research for prevention, care, and cures at the Ernest N. Morial Convention Center. Key themes will include: Advancing obesity and metabolic health: Prevention, early detection, and disease modification: Improving cardiometabolic outcomes: Transforming care through innovation and access: New research will highlight how technology, artificial intelligence, and implementation strategies are reshaping diabetes care—reducing treatment burden, expanding access, and enabling more person-centered care. Advancing beta cell replacement and cure strategies: Fostering innovation: On Saturday, June 6, from 4:30-6:00 p.m., the Innovation Challenge, which debuted in 2023, invites emerging companies to pitch novel ideas to improve the lives of people living with diabetes. A panel of judges, with input from a live audience, determines which contestants will earn a private audience with potential funders. XX Tidepool, the nonprofit leader advancing innovation in diabetes technology, announced that Tidepool+ Direct Connect is now available through the Epic Showroom. Built on SMART on FHIR, Direct Connect brings interactive diabetes device data directly into Epic workflows, helping clinicians use patient data during routine care. "Tidepool has always focused on making diabetes data more accessible and actionable," said Brandon Arbiter, CEO. "We're excited to empower clinicians using Epic with insightful, intuitive patient data that fits directly into their encounter workflow so they can use it to improve care in the moment it matters."   Tidepool+ Direct Connect supports scalable deployment across Epic-enabled health systems. This architecture enables faster, more intuitive rollouts, enhancing Tidepool's existing EHR integration capabilities.   Direct Connect is part of Tidepool's ongoing work to improve how clinicians can use timely and relevant diabetes device data during patient visits to help drive better health outcomes.   The feature is now available in the Connection Hub of the Epic Showroom.   https://www.businesswire.com/news/home/20260527780274/en/Tidepool-Launches-in-Epic-Showroom-to-Bring-Diabetes-Device-Data-into-the-Point-of-Care XX

On this episode of Ask Roz & Mocha, things get hilariously real as the crew debates who's most likely to get divorced—sorry Shem, the verdict may already be in. Listeners also chime in with some truly on-brand ideas, including the perfect final resting spot for Roz (hint: it involves his beloved lawn and a certain street in Acton). Plus, a blast from the past resurfaces with the legendary wrapping paper that only boob tape could tame—does it still make an annual appearance? And to top it all off, the gang imagines their own Iron Man-style suits, revealing just how chaotic (and revealing) their personalities really are.

This is Part D of D of Undressing Jack the Stripper, an eight part series made in conjunction with the True Crime Enthusiast podcast.From the late 1950s to the mid-1960s, the bodies of eight sex-workers (Elizabeth Figg, Gwynneth Rees, Hannah Tailford, Irene Lockwood, Helen Barthelemy, Mary Fleming, Margaret McGowan and Bridget O'Hara) were found dumped in or near the River Thames in West London.Panic spread that a sadistic serial killer was on the loose who targeted young petite brunettes; stripped and strangled them, dumped each body within weeks and streets of each other. Yet with not a single witness to his crimes, even though several suspects have since been named, with no convictions, it's a series of killing which remains a mystery to this day.After the success of their ten-part series, Psychopath: Two Side of Patrick MacKay, Mike at Murder Mile and Paul at the True Crime Enthusiast join forces once again to bring you an eight-part crossover series about one of Britain's most infamous unsolved serial killing – Jack the Stripper.This episode is about Helen Barthelemy & Mary Fleming.Location: Civil Defence Building, Hornton Street, Kensington, London, W8Date: Wednesday 25th of November 1964 at 1:30pm (body found)Victims: Margaret McGowan Location: Heron Trading Estate in Acton, West London, London, W3Date: Tuesday 16th of February 1965 (body found)Victims: Bridget O'HaraSeven time nominated at the True Crime Awards, Independent Podcast Awards and the British Podcast Awards, Murder Mile is one of the best UK / British true crime podcasts covering only 20 square miles of West London. It is researched, written and performed by Michael of Murder Mile UK True Crime Podcast with the main musical themes written and performed by Erik Stein and Jon Boux of Cult With No Name and additional music, as used under the Creative Commons License 4.0. A full listing of tracks used and a full transcript for each episode is listed here and a legal disclaimer.Sorry, but the ALWAYS TRUE CRIME CROSSOVER at Crossed Wires Festival has been cancelled due to poor ticket sales. You should have received a full refund from your ticket purchaser, but if you have any problems, let me know, and I can try and put you in touch with right people. Sorry for the inconvenience. Follow me on SOCIAL MEDIA · Instagram· FaceBook· ThreadsSUBSCRIBE via PatreonSupport this show http://supporter.acast.com/murdermile. Hosted on Acast. See acast.com/privacy for more information.

Lora Copley never thought she'd be editor of The Banner. When her name first came up, she sent back a crying-laughing emoji. She was a campus minister in Iowa, not a journalist. But on a Saturday afternoon — the day before the application deadline, while her daughter was napping — the thought wouldn't leave her alone. She put in her résumé fully expecting to be politely declined, and instead found herself in Florida, at the Multiply 222 conference, receiving a call she hadn't seen coming. In part one of our conversation, Lora tells the story of how God redirected her into the Banner, and what she's learned about the publication, the denomination, and the work in front of her. This episode is for anyone who has thrown the Banner in the recycling and assumed nothing was going to change. Lora walks us behind the curtain — how feature articles get planned a year in advance, how unsolicited columns come in, how the Our Shared Ministry pages work, and why submissions have nearly tripled since December. She's not asking the CRCNA to manage decline. She's reading Hebrews 11 and the COD report side by side and refusing to pretend the gospel has shrunk. She wants to know what God is doing in Houston and Pease, Minnesota, and Acton, Ontario — and she wants The Banner to be the place where we hear about it. The payoff is the moment Jason calls out in real time: he's been one of the Banner's most vocal critics for six years, and he's genuinely encouraged. Lora's vision — a publication that speaks with and within the denomination, that helps the CRCNA know both God and itself, that holds Calvin's twin pillars of wisdom together — is exactly the kind of cross-pollination a denomination in reformation requires. Part two picks up with Lora's dreams for the next five years, the Banner's confessional turn, and her nerves heading into Synod. Timestamps: 0:00 — Intro 1:59 — How a crying-laughing emoji turned into a call to the Banner 5:30 — Hebrews 11 and refusing the script of decline 9:06 — Stepping into a new role: the steep learning curve 11:30 — December deep dive into Synod 2025 12:27 — What Synod 2025 actually asked of The Banner 14:00 — Speaking with and within the denomination 15:30 — Calvin's twin pillars: knowing God and knowing ourselves 17:59 — From interim editor to candidate for permanent editor 19:30 — A call to and a release from 20:48 — Behind the scenes: how Banner articles come together 22:00 — Features, columns, and Our Shared Ministry 25:57 — Why submissions tripled — and what that means for stewardship 27:38 — Widening the pool and breaking the echo chamber Join and support us on Substack: https://themessyreformation.com/ Intro music by Matt Krotzer

Keith Acton is a Canadian former professional ice hockey centre who played 15 seasons in the National Hockey League, with the Montreal Canadiens, Minnesota North Stars, Edmonton Oilers, Philadelphia Flyers, Washington Capitals and New York Islanders between 1980 and 1994. Keith and Terry Ryan to talk about Hockey Helps the Homeless and share many stories from his coaching and playing career.  You can now watch episodes of Tales with TR on YouTube! Head over to https://www.youtube.com/@THPN to watch the latest episode   Check out TerryRyan.ca Welcome to Tales with TR: A Hockey Podcast presented by The Hockey Podcast Network. Join former Montreal Canadiens' first-round draft pick & Shoresy star Terry Ryan, as he talks about the sport of Hockey, brings on various guests, and shares tales of his life and professional hockey career.   Host: Terry Ryan @terryryan20 Network: @hockeypodnet Editor: Isha Jahromi - "The City Life Project" on Youtube Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Matt speaks with Casey Kennedy, co-founder of Acton Academy Calgary Central, about what makes the Acton model different from traditional schooling: guides instead of teachers, Socratic discussions instead of lectures, mastery instead of grades, and an emphasis on letting kids struggle, fail, and become passionate about the process of learning itself. Casey also explains why she and her husband started the school for their daughter, how her earlier work in Dallas and Sierra Leone shaped her view of education, and why she believes every child has a “genius” that education should help uncover. References Acton Academy Calgary Central https://www.actoncentral.org/ Acton Academy https://actonacademy.org/ The One World Schoolhouse - Salman Khan https://a.co/d/0dI4FOkK Khan Academy https://www.khanacademy.org/ Montessori education and mixed-age classrooms https://montessori-ami.org/trainingvoices/mixed-ages-montessori-environment Thanks to Our Patrons Thanks to our patrons, including Kris Rondolo, Amy Willis, and Christopher McDonald. To support The Curious Task, visit: https://patreon.com/curioustask

David Waldman continues his travels, seeing the sights, absorbing the history, browsing the merch, recording a podcast! Donald K. Trump is a loser, and everyone knows it, even him, or at least he'll be figuring that out real soon. The Trump-Iran war is a catastrophe turning into a bigger catastrophe that Trump's tacos can no longer save. In fact, if Trump doesn't crash soon, we all will crash big. MAGA loves failures that pretend they aren't. That was Trump Media's selling point. The DOJ quit minding laws a while back, now they're just the muscle to take down 78-year-old scientists. A few Indiana state Senators didn't like rigging elections, so Trump had them 86'd, if you pardon the term. The SAVE act would have sunk democracy, but not passing it earns Gop pity points. Ohio's back, baby! Well, almost. Now we need to get Sherrod Brown and Dr. Amy Action! Acton into office.

GOP Strategist Bob Clegg reviews last night's primary which seemed to be as expected including Vivek vs. Dr. Acton

It's In The News - where we bring you the top diabetes stories and headlines happening now. This week, Tzield approved down to age one and over, Omnipod trials for fully closed loop, Tandem approved for pregnancy, Eversense 365 launches in Europe, generic Ozempic in Canada, an award for the T1D Barbie and more.  Announcing Community Commericals! Learn how to get your message on the show here. Don't miss our in-person events: www.diabetes-connections.com/events  Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Okay.. our top story this week: XX The U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) for use in children in stage 2 type 1 diabetes (T1D) ages one and older. The approval expands the previous indication from those aged eight and above and was granted under a priority review process. This decision is supported by one-year data from the PETITE-T1D Phase IV study, which evaluated the safety and pharmacokinetics of Tzield in children under eight years old. Tzield was approved for use in individuals 8+ in stage 2 T1D in 2022. Since then, we have been working to expand the eligible population. This expansion effort includes individuals in stage 3 T1D, who can preserve endogenous insulin production for longer when they take Tzield and, most notably today, children in stage 2. https://www.breakthrought1d.org/news-and-updates/tzield-approved-for-children-ages-one-and-older-in-stage-2-t1d/   XX Big write up in the journal Pediatrics about screening for type 1. Citing the 2025 ADA Standards of Care in Diabetes, the opinion piece talks about how to engage the greater healthcare community.  It says: We aim to encourage the development of strategies to emphasize the importance of T1D early detection, integrate screening into routine health care encounters, and support implementation of T1D screening. Pediatricians and other primary care clinicians are well positioned for greater collaboration with the multidisciplinary team, ensuring early detection, timely intervention, and improved outcomes. https://publications.aap.org/pediatricsopenscience/article/2/2/1/207272/Type-1-Diabetes-Screening-in-Pediatrics-Putting?autologincheck=redirected   XX More info about GLP-1 drugs and people with type 1. New study shows off label use did not lead to DKA or pancreatitis in a large 1-year single-center study. Moreover, GLP-1 agonist use in people with T1D was associated with lower overall rates of hospitalization, as has occurred in type 2 diabetes Although GLP-1 agonists are not approved by the FDA for T1D management, off-label adjunctive use has risen for those with obesity. Semaglutide was the most commonly-used GLP-1 (65.5% of GLP-1 users) followed by tirzepatide (23.5%). The rest were using the older-generation drugs: liraglutide or dulaglutide. Lots more information to come on type 1 and glp 1-s in upcoming studies. https://www.medscape.com/viewarticle/use-glp-1s-type-1-diabetes-not-linked-increased-dka-2026a1000d56 XX Health Canada ‌​has approved the first generic ​version of ​Danish ⁠drugmaker ⁠Novo ‌Nordisk's Ozempic drug. In January 2026, the Canadian patent for Ozempic will expire, paving the way for cheap generic versions of the semaglutide injections that help regulate blood sugar levels and appetite. Health Canada said this generic, like existing products, is indicated to be used for the "once-weekly treatment of adult patients with Type 2 diabetes to manage blood sugar levels." With three generics on the market, Tadrous said the price could drop to about $100 or less, depending on their dose. Health Canada said it's currently reviewing eight other generic submissions by different companies and expects to make a decision on these in the next few weeks and months. https://www.cbc.ca/news/health/ozempic-generic-health-canada-9.7180566 XX  Insulet has enrolled the first participant in a pivotal study for its fully closed-loop (FCL)A automated insulin delivery (AID) system for type 2 diabetes (T2D  The participants are between 18 – 75 years of age, living with T2D and using insulin (basal-bolus or basal-only). The Company received Investigational Device Exemption (IDE) approval in March 2026 from the U.S. Food and Drug Administration (FDA). The Company plans to submit a 510(k) filing to the FDA in 2027 and launch its FCL AID system for T2D in 2028.   XX insulet Corporation (PODD) has initiated a voluntary recall of certain lots of its Omnipod 5 insulin delivery Pods in the U.S. after detecting that some devices had a manufacturing defect that causes insulin leakage.   Patients using the affected devices could risk experiencing high blood glucose levels due to insufficient insulin delivery, the Acton, Massachusetts-based MedTech disclosed in a statement late Thursday. The company has already notified the FDA about the recall, which it said will affect nearly 1.5% of Omnipod 5 pod units it manufactures annually. The customers were advised to immediately seek a product replacement at no cost if a Pod from a defective lot is currently in use. https://www.msn.com/en-us/money/companies/insulet-recalling-certain-defective-omnipod-insulin-delivery-devices/ar-AA1YyslT?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1&bundles=feat-es2020-c XX Tandem Diabetes Care (Nasdaq:TNDM) gets FDA clearance for its automated insulin delivery (AID) technology for use in pregnancy. The FDA cleared the company's Control-IQ AID technology for use in what they call: pregnancy complicated by type 1 diabetes mellitus. Tandem says t:slim X2 and Mobi are the first and only commercially available AID systems cleared for use during pregnancy in the U.S. https://www.drugdeliverybusiness.com/tandem-fda-clearance-aid-pregnancy-t1d/ XX Tandem also issued an urgent medical device correction for a software problem with its Mobi insulin pumps. The malfunction may cause insulin delivery to stop, causing high blood sugar if not addressed, the Food and Drug Administration said in a Wednesday recall notice. We told you about this back in October when Tandem sent a letter to customers notifying them of the fault and instructing them to update their pump software as soon as possible. The FDA now issued a class one recall, the most serious type. We just released a bonus episode all about Tanem – tubeless mobi and what else is in the pipeline. You can listen to that wherever you are listening to this.. it's the episode just before this one. https://www.medtechdive.com/news/tandem-recalls-mobi-insulin-pumps-over-software-malfunction/818260/   XX Switching CGMs didn't make a measurable difference for adults using MiniMed's pump system. In a real-world analysis presented at the International Conference on Advanced Technologies & Treatments for Diabetes, researchers found that CGM metrics for patients who switched from the Guardian 4 sensor (MiniMed) to Instinct by Abbott were able to maintain a time in range of greater than 75%. "When it comes to the automated insulin delivery system ... I think the sensor matters less and the system matters more," Viral N. Shah, MD, professor of medicine in the division of endocrinology and metabolism and director of diabetes clinical research at Indiana University Center for Diabetes and Metabolic Diseases, said during a presentation. "Having a different sensor with the system, I think the [glycemic] outcomes will still be what you want." I'm including this because the headline here seemed to indicate no CGM makes a difference, but this study only looked at two. https://www.healio.com/news/endocrinology/20260401/switching-cgm-sensors-does-not-impact-glycemic-outcomes-with-automated-insulin-delivery   XX Vitamin D supplementation may help delay or prevent disease progression in people with prediabetes.. in people who have specific variants in their vitamin D receptor gene. This was found after a second look at large study where researchers found vitamin d really did make a difference.. a second look with people who had a specific gene variation had much better results. "More research is needed to see if there are other factors that are associated with risk reduction." https://www.medicalnewstoday.com/articles/vitamin-d-supplements-help-prevent-type-2-diabetes-right-gene-variants   XX Senseonics (Nasdaq:SENS) announced today that it initiated the first European launch of its Eversense 365 continuous glucose monitor (CGM). The launch comes a few months after the company picked up CE mark for the long-term, implantable CGM in January. Eversense 365 is the world's first 365-day CGM system. It also holds clearance as an integrated CGM (iCGM) system, meaning it can work with compatible medical devices. Those include insulin pumps as part of automated insulin delivery systems, like the Sequel Med Tech twiist system. The company said it made Eversense 365 available to the first patients in Sweden. It plans to bring the sensor to Germany, Spain and Italy in the coming weeks https://www.drugdeliverybusiness.com/senseonics-launches-eversense-365-europe/ XX A machine learning model can improve genetic prediction of type 1 diabetes by as much as 10%, show results from a University of California, San Diego study.   The researchers used the machine‑learning model T1GRS to improve on a gold standard polygenic genetic risk score used to predict who is likely to develop the condition called GRS2. The GRS2 polygenic risk score has been widely tested and can be used to predict newborns who are at high risk of developing type 1 diabetes. While early prediction can't necessarily stop the disease it can help to prevent emergencies like diabetic ketoacidosis at diagnosis, allow families time to prepare and could allow use of therapies to delay onset of the condition. In this study, Gaulton and colleagues carried out a genome‑wide association study in 20,355 people with type 1 diabetes and 797,363 non‑diabetic Europeans, as well as a further analysis around the MHC region in 10,107 diabetic and 19,639 nondiabetic individuals. https://www.insideprecisionmedicine.com/topics/molecular-dx/machine-learning-tool-helps-improve-type-1-diabetes-prediction/ XX Sen. Mark Warner (D-Va.) said Monday that he will return to the upper chamber this week after taking time off for the death of his daughter, Madison.   The Virginia senator wrote on the social platform X, "As we remember our incredible daughter, Maddy, my family has been deeply touched by the outpouring of support we've received. Thank you to everyone for your kind words." Madison Warner, 36, died earlier this month after a decades-long battle with juvenile diabetes and other health issues. Mark Warner and his wife, Lisa Collis, wrote in a statement last Monday that they were "heartbroken beyond words" by their daughter's passing.   On Monday, the former Virginia governor said his daughter "was a deeply empathetic and engaged person" and that "as recently as the day she passed, she was full of ideas and suggestions" for him, including how he could improve his social media presence.   "She used to say to me: 'Dad, you have the power — you have to use it.' She pushed me to make the most of my position, to use my seat in the Senate to help people in meaningful ways," he added.       "If I can find any solace during this time, it's that I have the enormous privilege to serve Virginians and the responsibility to keep working for a better, more just world in Maddy's name."   Warner concluded, "I look forward to returning to the Senate this week and continuing that essential work."   Madison Warner is survived by two younger sisters.     An estimated than 2.1 million Americans, including about 314,000 children and adolescents younger than age 20, have diagnosed type 1 diabetes as of March — which is what juvenile diabetes is commonly called — according to the CDC's National Diabetes Statistics Report.   An estimated 11 million U.S. adults have undiagnosed diabetes, the report notes.   Symptoms of type 1 diabetes include feeling more thirsty than usual, urinating a lot, bed-wetting in children who have never done so, feeling very hungry and losing weight without trying, according to the Mayo Clinic. https://thehill.com/homenews/senate/5851605-mark-warner-diabetes-death/ XX Mattel, Inc. and Breakthrough T1D just won a Gold Halo Award for Best Cause Product Initiative for the launch of the first Barbie with T1D.  The Halo Awards recognize the most outstanding corporate social impact efforts over the past year.

Andy Acton returns to the Dental Leaders hot seat for a proper deep-cut conversation about the business of owning a dental practice — from first purchase right through to the exit. Payman and Andy cover the current market (spoiler: banks still love dentists, and buyers far outnumber sellers), before getting into the real meat of the episode: owner fatigue. Andy breaks down the five categories of burnout he's observed across 25 years of working with practice owners, and it's the kind of honest, unglamorous stuff that rarely gets aired. There's also a brilliant success story about a single-surgery practice that became a near-£2 million sale in four years, plus some sharp advice on what not to do in your first month of ownership. Whether you're thinking about buying, selling, or just trying to work out why you're so tired, this one's well worth your time.In This Episode00:00:50 – Andy's business portfolio and the FTA family of companies 00:03:10 – Market snapshot: supply, demand and the state of play in December 2025 00:04:15 – Squats vs acquisitions 00:07:35 – What buyers are really looking for 00:10:15 – Occupancy levels and the case for maximising before expanding 00:13:10 – Corporates vs independents: deal structures and flexibility 00:17:10 – Patient attrition when the owner leaves 00:20:25 – Horror stories and success stories: flipping practices 00:28:15 – Young dentists buying early and the bank of mum and dad 00:31:05 – Would Andy encourage his kids to become dentists? 00:33:20 – Owner fatigue: five categories of burnout 00:35:25 – How valuation methods have evolved over 25 years 00:42:45 – Raising finance and banking terms 00:45:45 – The ownership lifecycle and signs of fatigue 00:55:55 – Sales readiness: the checklist 01:05:30 – Business education and the case for teaching it at school 01:13:05 – Understanding financial accounts and key KPIs 01:18:25 – Quick-fire: favourite business book, business hero, and the green lights philosophy 01:25:15 – Dental leaders who inspire Andy 01:32:25 – Fly on the wall moment: the Man United treble changing roomAbout Andy ActonAndy Acton is co-founder of Frank Taylor Associates, one of the UK's leading dental practice sales and valuation firms. Alongside his business partner Chris, Andy has built a portfolio of dental-focussed businesses, including FTA Finance, FTA Media, FTA Wealth, and the Principals Club — a members-only community for independent practice owners. He has worked in the dental sector for over 25 years.

Monday the 15th of August 2022 at 3pm, Flat 72 on the first floor of Clariat Court was the home of Aziza Bennis, a 58-year-old school dinner lady and a mother-of-two, where she had raised her daughters as a single parent. To their neighbours, she was liked, as were her family. But on the afternoon of Monday the 15th of August 2022, she was frenziedly attacked and stabbed to death by her eldest daughter, Hanaa. But why?Was she deranged, traumatised or defending herself, and what was the truth?Location: Flat 72, first floor, Clariat Court, Boddington Gardens, Acton, London, W3Date: Monday the 15th of August 2022 at 3pmVictims: Hanaa Bennis/Aziza BennisCulprit: Aziza Bennis/Hanaa BennisSeven time nominated at the True Crime Awards, Independent Podcast Awards and the British Podcast Awards, Murder Mile is one of the best UK / British true crime podcasts covering only 20 square miles of West London. It is researched, written and performed by Michael of Murder Mile UK True Crime Podcast with the main musical themes written and performed by Erik Stein and Jon Boux of Cult With No Name and additional music, as used under the Creative Commons License 4.0. A full listing of tracks used and a full transcript for each episode is listed here and a legal disclaimer.Follow me on SOCIAL MEDIA · Instagram· FaceBook· ThreadsSUBSCRIBE via PatreonSupport this show http://supporter.acast.com/murdermile. Hosted on Acast. See acast.com/privacy for more information.

Before Ohio holds its primary, the presumptuous GOP candidate for Governor Vivek Ramaswamy is running a negative ad against the presumptive Democrat candidate Dr. Amy Acton. Ramaswamy's ad attempts to gaslight voters about Acton's role as the Director of the Ohio Department of Health at the start of the COVID pandemic in 2020. The ad falsely claims Acton acted outside her authority to postpone the March 2020 primary election. Ohio Republicans have been wanting voters to forget the truth of their inaction during the pandemic and undermining the state's response for political reasons since 2020.We look at Ohio Representative Josh Williams who is the only black Republican in the Ohio House and he is running for Congress in Ohio's 9th District. He claims DEI and affirmative action keep the Black community stuck in poverty and he vocally supports anti-abortion stances, often echoing sentiments that appeal to a predominantly white anti-abortionist base like repeating the false and harmful narrative of abortion as a form of genocide within the Black community. Williams should be the last person holding negative views about policies and programs that give a hand up out of poverty since he himself needed and used that help when he was bed ridden for six years and had no high school diploma yet is now a lawyer and teaches law at a local college while serving as a state representative.Finally we look at the fight between President Trump and the Pope. It is particularly striking that figures like Trump and JD Vance, especially Vance's recent conversion to Catholicism, feel emboldened to critique religious authorities, including the Pope, on theological grounds that contradict their own political alignments. This speaks to a broader trend of politicization of religion where moral authority is wielded selectively. We see that politicization in every level of government from the local to the federal. It is a trend that needs to be stopped.Full Show Notes & Links UsedSend us Fan MailSupport the showSubscribe to our free newsletterCheck out our MerchFollow us on BlueskyFind us on Twitter(for now) Find us on InstagramFind us on Counter SocialFind us on Mastadon

Brian is joined by Jack Windsor from the Ohio Press Network about the latest news and issues in Ohio politics. Jack shares his insights on the state's voter ID laws, pointing out a loophole that allows voters to submit absentee ballots without showing a photo ID. He also discusses the upcoming gubernatorial election, where Amy Acton is running against Vivek Ramaswamy. Jack weighs in on the controversy surrounding Acton's hiring of a high-profile law firm to defend against allegations of fake tweets. The conversation also touches on a bizarre bill proposed by a Democrat lawmaker that aims to protect children from indecent performances.See omnystudio.com/listener for privacy information.

Riley McGilloway is a third-generation firefighter, carrying on a family legacy rooted in service, pride, and hard work. Raised in Acton, Ontario, he grew up around the fire service and developed a deep respect for the job early on—something that continues to drive how he operates today. In addition to his role on the truck, Riley is an instructor with Southwest Fire Academy, where he's committed to helping develop the next generation of firefighters. He believes the job is earned daily—through training, discipline, and showing up ready to perform when it counts. Riley also serves as President of True North FOOLS, leading an organization focused on brotherhood, training, and creating real opportunities within the fire service. Through sold-out events, hands-on training, and a strong culture, his mission is to make those around him better and give back to the job. Known for his relentless mindset, Riley approaches his career with the belief that he's never “arrived.” He continues to push himself through training, leadership, and mentorship as he works toward the next step. Whether on the fireground, in the classroom, or building something bigger for the fire service community, he's committed to leaving it better than he found it through hard work. @rileymcgilloway @truenorthfools Sponsorship: @southwest_fire_academy Editing: @bradshea Marketing: @m.pletz Administration: @haileygreenfitness Partnership: @firefighternationhq Mid-roll Sponsor: @rescue_squad_ironworks @ffrescueontario @firefighterfitnesscanada

The Springs fire is 45% contained near Moreno Valley and the Crown fire is 74% contained near Acton, after they broke out yesterday, fueled by Santa Ana winds. LA28 Olympic ticket buyers balked at a 24% service fee. Indie rock star Mitski finishes up her Hollywood High School residency tonight. Plus, more. Support The L.A. Report by donating at LAist.com/join and by visiting https://laist.com Visit www.preppi.com/LAist to receive a FREE Preppi Emergency Kit (with any purchase over $100) and be prepared for the next wildfire, earthquake or emergency!Support the show: https://laist.com

Send a textIt's kidding season for most dairy goat producers in the United States right now.  It's a time of year where all of us are anxious and hopeful that everything turns out ok.  The reality is producers can be met with easy to very difficult situations when it comes to kidding.  This week Danielle and Jon welcome Dr. Lauren Acton to talk about the different presentations during kidding and how to approach them.  You won't want to miss this episode!LEAVE A REVIEW FOR THE SHOWDr. Acton's herdwe have merch!

In this episode, Dan Hugger speaks with Steve Barrows, chief operating officer of the Acton Institute, about entrepreneur and pro-democracy activist Jimmy Lai, who was recently sentenced by a Hong Kong court to 20 years in prison. Subscribe to our podcasts Watch this podcast here Jimmy Lai's 20-Year Sentence Follows Beijing's Playbook on Dissent | […]

Good Vibe Tribe: Discovery Museum in Acton full 304 Thu, 26 Feb 2026 11:43:49 +0000 P6Ik4YonexABd5kcfPLTgBzbfeJL5l3z latest,wbmx,society & culture Karson & Kennedy latest,wbmx,society & culture Good Vibe Tribe: Discovery Museum in Acton Karson & Kennedy are honest and open about the most intimate details of their personal lives. The show is fast paced and will have you laughing until it hurts one minute and then wiping tears away from your eyes the next. Some of K&K’s most popular features are Can’t Beat Kennedy, What Did Barrett Say, and The Dirty on the 30! 2024 © 2021 Audacy, Inc. Society & Culture False https://player.amperwavepodcasting.com?feed-link=h

In this episode, Dan Hugger speaks with Claire Lai, law student and daughter of entrepreneur and pro-democracy activist Jimmy Lai, about her father's unjust imprisonment and powerful Christian witness. ⁠Subscribe to our podcasts⁠ ⁠Watch this podcast here⁠ ⁠The Hong Konger: Jimmy Lai's Extraordinary Struggle for Freedom [Full Film]⁠ ⁠Stephen Barrows Explains the Jimmy Lai Verdict⁠ […]

With petitions filed and the 2026 statewide races officially underway, Ohio's political landscape is beginning to take shape. The governor's race is already drawing national attention, with former Ohio Department of Health Director Amy Acton emerging as the sole Democratic candidate and Vivek Ramaswamy entering the Republican primary with endorsements from both Donald Trump and the Ohio Republican Party. But beyond the top-line names, there are deeper dynamics at play—primary challenges, party infrastructure, grassroots pushback, fundraising strategy, and the broader question of whether this election cycle presents a real opportunity for Ohio Democrats. To help us unpack it all, I sat down with David DeWitt, editor-in-chief of the Ohio Capital Journal. We walk through who's running, what the Republican primary could mean for the general election, why Democrats cleared the field for Acton, and how historical midterm patterns might shape the outcome. We also zoom out to look at the other statewide races—Attorney General, Secretary of State, Auditor—and why those offices matter more than many voters realize, especially when it comes to redistricting, ballot access, and how Ohio's laws are defended in court. Shownotes Ohio Capital Journal Amy Acton (D) Vivek Ramaswamy (R) Casey Putsch (R) Heather Hill (R) Renea Turner (R) Donald Kissick (L) Transcript on page 2. The post Who’s Running for Ohio Governor? appeared first on The Confluence Cast.

We've all been there. Feeling stuck with a problem because no one in our life can relate. Or because the one person we need to talk to … won't. Or can't. Enter Yowei Shaw and the show Proxy. Proxy is built on a simple idea: no one is ever as alone with their problem as they think. So Yowei brings in a proxy, a perfect stranger, to help her guests work through their dilemma. Today we're sharing the case of Brian, a journalist whose mother-in-law has Alzheimer's. Even though Brian knows she can't help misremembering things, he can't stop losing his patience with her, and with himself.  This episode was mixed for Science Vs by Bobby Lord. – Resources from Claudia on dementia caregiving, caregiving in general, and acceptance and commitment therapy (ACT): On understanding dementia Dementia Reimagined: Building a life of joy and dignity from beginning to end by Tia Powell (and this accompanying Fresh Air episode) On preventing/addressing emotional or behavioral changes associated with dementia When a Family Member Has Dementia: Steps to Becoming a Resilient Caregiver by Susan M. McCurry On acceptance and commitment therapy (not specifically related to caregiving) Get Out of Your Mind and Into Your Life The New Acceptance and Commitment Therapy by Steven C. Hayes The Happiness Trap: How to Stop Struggling and Start Living by Russ Harris Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, Dan Hugger speaks with Steve Barrows, chief operating officer of the Acton Institute, about entrepreneur and pro-democracy activist Jimmy Lai, who was recently sentenced by a Hong Kong court to 20 years in prison. Subscribe to our podcasts Watch this podcast here Jimmy Lai's 20-Year Sentence Follows Beijing's Playbook on Dissent | […]

What happens if Roz and Mocha secretly fall in love on the show — would they have to hide it, and how jealous would Maurie get? Plus, should you tell your partner when someone flirts with you, Roz shares his favourite and least favourite parts of growing up in Acton, and we debate whether you call out someone who leaves the washroom without washing their hands. We also get into the pain of blowing a kiss to the wrong person and the ultimate bread‑slice controversy: do you eat the ends of the loaf?

supportjimmylai.com

This month on the Acton Rundown Dan & Mark chat about upcoming Acton events and new video content. Winter 2025 Religion & Liberty: Orthodox Social Thought and the Public Square by Anne Bradley The Upside-Down Kingdom of Jesus of Nazareth by Jordan Ballor   Video content: Dylan Pahman Breaks Down the History of Economic Thought Isaac Willour […]

In this episode, Dan Hugger speaks with Noah Gould, Alumni and Student Programs Manager at the Acton Institute, about the shape that religion and faith in God takes for those who journey from atheism and skepticism to the Christian faith. Why are high-profile skeptics taking a fresh look at the Christian faith? Are we experiencing more […]

In this episode, Dan Hugger speaks with Dave Hebert, a senior research fellow at AIER and an affiliate scholar here at the Acton Institute, about the state of the American economy, economic policy, and how American politics on both the left and the right is increasingly economically illiterate. How is the U.S. economy doing? What […]

In this episode, Dan Hugger speaks with Isaac Willour, an analyst at Bowyer Research, America's leading pro-fiduciary proxy consulting firm, about all things ESG, an investing principle that prioritizes environmental issues, social issues, and corporate governance. What is ESG and how does it influence corporate governance and investment? What moral responsibilities do shareholders have in […]

This month on the Acton Rundown, Dan & Mark chat about upcoming Acton events and new video content.   Winter 2025 Religion & Liberty: Why Orwell Still Matters by John Rodden Video content: Stephanie Slade Is Chronicling the New Right Peter Boettke Is Teaching the Humanistic Foundations of Austrian Economics Rev. Robert A. Sirico Responds to […]

In this episode, Dan Hugger speaks with Dylan Pahman, research fellow at the Acton Institute and founder and president of the St. Nicholas Cabasilas Institute for Orthodoxy & Liberty, about his account of the history of economic thought found in his new book, The Kingdom of God and the Common Good: Orthodox Christian Social Thought (Ancient Faith, […]

In this episode, Dan Hugger speaks with Kris Mauren, co-founder and president of the Acton Institute, about all things Acton. What was the original, animating idea behind the founding of the Acton Institute? Why a think tank? What makes Grand Rapids so grand? What are the greatest challenges Acton faces in fulfilling its mission? What […]

MeidasTouch host Ben Meiselas reports on Republicans and Independents in Ohio turning against Trump and MAGA ahead of the critical 2026 governor's race, as Democratic candidate Dr. Amy Acton surges past MAGA candidate Vivek Ramaswamy. Meiselas also interviews Dr. Acton about the race. Learn more about your ad choices. Visit megaphone.fm/adchoices